About Cunesoft Exit

Headquartered in Munich, Germany, Cunesoft’s online software solutions have been built to provide industry-breaking value for life sciences organizations. The software suite is available in individual but integrated modules. Customers select their relevant modules for their needs.

A smart integration of best practice processes such as the preparation of drug submissions combined with an automatic electronic submission publishing function, reduces the process time by 90%. Other software modules support critical quality assurance process and ensure quality compliance while delivering significant process reduction time. The system has been architected to support collaboration across company boundaries and via that help life sciences organizations to become faster and more effective.

Produkt Cunesoft

The SaaS (Software as a Service) concept allows all customers to benefit of an immediate system availability. Implementation times are reduced from months to hours. System maintenance is provided centrally by Cunesoft and reduces costs on customer’s side. Typical project ROI’s are below 6 months.

Cunesoft’s positioning is very attractive for companies of all sizes. Small organizations find very attractive entry level price models while large organizations benefit by its scalability. Currently drug manufacturers from emerging regulated markets, biotechnology companies, generics organizations and originator drug producers are happy and referenceable customers of the Cunesoft online software platform.

Press releases

15. January 2020

HTGF Portfolio Company: Cunesoft joins forces with Phlexglobal

The Munich-based Cunesoft GmbH, an innovative provider of cloud-based intelligent regulatory data management software and services for the life sciences industry, announced today that it has been acquired by Phlexglobal from current investors including Bayern Kapital, High-Tech Gründerfonds and OCCIDENT. Phlexglobal, the leading provider of Trial Master File (TMF) software and expert services joins forces with Cunesoft, which expands the company’s portfolio of best-of-breed technologies desi
7. April 2016

Cunesoft receives a seven-digit Series-A financing from Occident Group, High-Tech-Gruenderfonds and Bayern Kapital

The Munich based Cunesoft GmbH, an innovative software provider of cloud-based regulatory master data management solutions for the pharmaceutical industry, today announced that it has successfully completed an undisclosed seven-digit series-A financing round. The participants in this new round of financing included the Swiss based lead investor Occident Group and the existing investors High-Tech-Gruenderfonds and Bayern Kapital, who also previously invested in Cunesoft in October 2014. The co
28. October 2014

High Tech Gründerfonds (HTGF) and Bayern Kapital invest in Cunesoft GmbH

Cunesoft GmbH, an innovative cloud software provider for regulatory document and submission management, specialized in the pharmaceutical industry, today announced that it successfully closed an investment round with High-Tech Gründerfonds and Bayern Kapital. The funds will be used to further internationalize sales activities as well as to expand the software’s capabilities. Within the pharmaceutical industry, the filing of the drug submission dossier involves critical and regulated pr

Info & Contact


Cunesoft GmbH
Luise-Ullrich-Strasse 20
80636 München

In portfolio

16. Oct 2014 – 23. Dec 2019